Taiwan · Delayed Price · Currency is TWD TSH Biopharm Corporation Company Description
TSH Biopharm Corporation Limited develops and markets pharmaceutical products in Taiwan.
The company offers prescription medication for cardiovascular, central nervous, gastrointestinal, and others.
It also provides MPap, a methylation-specific qPCR technology to detect the methylation status of CDO1 and BHLHE22 genes using cervical scraping; AlphaLiquid Detect, a hybrid capture NGS-based liquid biopsy test designed for MRD detection and surveillance in stage I-III solid tumor patients; AlphaLiquid 100, a liquid biopsy test designed for patients with advanced solid cancers; AlphaLiquid HRR, AlphaSolid, and AlphaSolid HRR, a tissue biopsy test designed for patients with advanced solid cancers.
The company was founded in 2000 and is headquartered in Taipei, Taiwan. TSH Biopharm Corporation Limited operates as a subsidiary of TTY Biopharm Company Limited.
| Country | Taiwan |
| Founded | 2000 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 76 |
| CEO | Sze-Yuan Yang |
Contact Details
Address: No. 3-1 Yuanqu Street Taipei, 11503 Taiwan | |
| Phone | 886 2 2655 8525 |
| Website | tshbiopharm.com |
Stock Details
| Ticker Symbol | 8432 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0008432006 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sze-Yuan Yang | President |
| Jung-Liang Kao | Senior Division Director of Finance Division and Chief Financial Officer |
| Chen-Ju Kan | Senior Manager of the Accounting Department |
| Yu-Chung Wu | Senior Director of Sales |
| Chuan-Hsu Chen | Senior Director of Marketing |
| Hsin-Young Liu | Company Secretary |